跳至主要内容
临床试验/NCT05971680
NCT05971680尚未招募3 期

the Effect of Vitamin B 1 on Menstrual Pattern After Insertion of the IUD.

Beni-Suef University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年7月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
入组人数
200
试验地点
1
主要终点
the duration of menstrual bleeding.

研究概览

简要总结

investigate the effect of vitamin B 1 on menstrual bleeding and spotting after insertion of the IUD.

详细描述

This study will be randomized controlled trial will be performed at the Obstetric and Gynecological Department at Beni-Suef University Hospital, Faculty of Medicine Target Population: All females with first time use of IUD inserted at the Obstetrics and Gynecology department through 3 months from the start of July 2023 till the end of November 2023.

Participants will be assigned in a 1:1 ratio to the use of vitamin B 1 or placebo, in accordance with a random table produced by an Excel program, with A being assigned to the intervention group and B to the control group. All women will sign a written informed consent prior to data collection.

Each woman within the intervention group will receive a packet containing 30 pills (vitamin B 1 or placebo), each month for three months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Females with first time use of the IUD
  • a history of normal menstrual bleeding with duration of 3 to 7 days without spotting, a menstrual cycle lasting 23 to 35 days,
  • use of 10 to 14 sanitary pads per cycle before IUD insertion
  • gravidity ranging between 1 and 4.

排除标准

  • Patients with cardiac, hepatic or renal diseases.
  • Patients with bleeding disorders.
  • Patients with systemic diseases.

研究组 & 干预措施

Vitamin B 1

Experimental

VITAMIN B1 (High Potency) 500mg

干预措施: VITAMIN B1 500mg (Drug)

Vitamin B 1

Experimental

VITAMIN B1 (High Potency) 500mg

干预措施: intra-uterine contraceptive device (Device)

control

Other

patient not subjected to treatment . only follow up

干预措施: intra-uterine contraceptive device (Device)

结局指标

主要结局

the duration of menstrual bleeding.

时间窗: 3 cycles ( 3 months / one month for each cycle)

days of menstruation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Abdallah Mohamed Salem

Lecturer of Gynecology and obstetrics Faculty of medicine Beni-Suef University

Beni-Suef University

研究点 (1)

Loading locations...

相似试验